The microRNA212 regulated PEA15 promotes ovarian cancer progression by inhibiting of apoptosis

Luo, Yonghong; Fang, Chuanchuan; Jin, Lan; Ding, Huafeng; Lyu, Yuanyuan; Ni, Guantai

doi:10.7150/jca.32886



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2020; 11(6):1424-1435. doi:10.7150/jca.32886 This issue Cite

Research Paper

The microRNA212 regulated PEA15 promotes ovarian cancer progression by inhibiting of apoptosis

Yonghong Luo¹, Chuanchuan Fang², Lan Jin¹, Huafeng Ding¹, Yuanyuan Lyu^1✉, Guantai Ni^1✉

1. Department of Obstetrics and Gynecology, The First Affiliated Hospital of Wannan Medical College, Wuhu, AnHui, 241001, P.R. China
2. Wannan Medical College, Wuhu, AnHui, 241001, P.R. China

Citation:

Luo Y, Fang C, Jin L, Ding H, Lyu Y, Ni G. The microRNA212 regulated PEA15 promotes ovarian cancer progression by inhibiting of apoptosis. J Cancer 2020; 11(6):1424-1435. doi:10.7150/jca.32886. https://www.jcancer.org/v11p1424.htm

Other styles

Abstract

PEA15 (Proliferation And Apoptosis Adaptor) is a 15kDa multifunctional phosphoprotein involved in various essential biological processes such as proliferation and apoptosis of cancer cells. Previous studies have demonstrated that PEA15 can promote the progression of many malignancies. In the present study, the expression of PEA15 in ovarian cancer and normal tissues analyzed in several databases and PEA15 was found to be significantly up-regulated in OC tissues compared to normal tissues. Immunochemical assays performed using 171 OC tissue specimens proved that the expression of PEA15 was remarkably positively correlated with the FIGO stage and associated with histologic subgroups of ovarian cancer. IHC assay for the two phosphorylation sites of PEA15 S116 and S104 was also performed. PEA15 high expression predicted a poor prognosis in OC patients analysed from K-M plot dataset. In addition, we proved knockdown of PEA15 inhibits OC cell proliferation and induces cell apoptosis by Bcl2 downregulation and Bax and cleaved Caspase-3 upregulation. Overexpression of PEA15 promotes the proliferative capacity of OC cells. Moreover, this study first discovered PEA15 expression in OC can be negatively regulated by microRNA212. Overexpression of miR-212 in ovarian cancer cells could cause downregulated the expression of PEA15 expression. Overexpression of miR-212 was found to exerted similar effects on the proliferation, and apoptosis of the ovarian cancer cells as that of PEA15 suppression. Additionally, overexpression of PEA15could at least partially abolished the effects of miR-212 on the proliferation, and apoptosis of ovarian cancer cells. In conclusion, our findings revealed PEA15 appears as a novel predictive biomarker, thus providing a valuable therapeutic target in OC treatment strategy.

Keywords: PEA15, miR212, Proliferation, Apoptosis, OC

Citation styles

APA

Luo, Y., Fang, C., Jin, L., Ding, H., Lyu, Y., Ni, G. (2020). The microRNA212 regulated PEA15 promotes ovarian cancer progression by inhibiting of apoptosis. Journal of Cancer, 11(6), 1424-1435. https://doi.org/10.7150/jca.32886.

ACS

Luo, Y.; Fang, C.; Jin, L.; Ding, H.; Lyu, Y.; Ni, G. The microRNA212 regulated PEA15 promotes ovarian cancer progression by inhibiting of apoptosis. J. Cancer 2020, 11 (6), 1424-1435. DOI: 10.7150/jca.32886.

NLM

CSE

Luo Y, Fang C, Jin L, Ding H, Lyu Y, Ni G. 2020. The microRNA212 regulated PEA15 promotes ovarian cancer progression by inhibiting of apoptosis. J Cancer. 11(6):1424-1435.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.